Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide plus linagliptin for acute ischemic stroke with hyperglycemia
ChiCTR2000035887Phase 4Not yet recruiting
- Sponsor
- Shanghai Sixth People's Hospital
- Start
- Aug 2020
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of liraglutide and linagliptin in ischemic stroke (2 arms), sponsored by Shanghai Sixth People's Hospital. Primary endpoint: Modified Rankin Scale score. Planned start Aug 2020; status: not yet recruiting.
02
Drugs
liraglutidelinagliptin
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on ChiCTR2000035887.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000035887.